International Stem Cell Corporation , a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that the Japan Patent Office has granted ISCO's patent covering methods of making a bank of human stem cells from parthenogenetically activated eggs, significantly strengthening the company's intellectual property position and partnering ability in Japan. "The new patent strengthens our position as a leader in regenerative medicine.
http://ift.tt/1GQRYx3
http://ift.tt/1GQRYx3
No comments:
Post a Comment